🏢 Company
AIM ImmunoTech
US biopharmaceutical company
📊 Rating
1 news mentions · 👍 0 likes · 👎 0 dislikes
📌 Topics
- Corporate Finance (1)
- Biotechnology (1)
- Capital Markets (1)
🏷️ Keywords
AIM ImmunoTech (1) · equity distribution agreement (1) · ATM offering (1) · capital raising (1) · clinical trials (1) · biopharmaceutical (1) · SEC filing (1)
📖 Key Information
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
📰 Related News (1)
🔗 Entity Intersection Graph
People and organizations frequently mentioned alongside AIM ImmunoTech:
-
SEC filing · 1 shared articles